Heart drug gets extended safety check in chinese patients
Disease control
Completed
This study followed Chinese patients with a heart-thickening condition who had already taken the experimental drug aficamten in an earlier trial. Researchers monitored them for long-term safety and side effects while they continued taking the medication. The goal was to understan…
Phase: PHASE3 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC